Literature DB >> 23886606

The unnatural history of an atrial septal defect: longitudinal 35 year follow up after surgical closure at young age.

Judith A A E Cuypers1, Petra Opić, Myrthe E Menting, Elisabeth M W J Utens, Maarten Witsenburg, Wim A Helbing, Annemien E van den Bosch, Mohamed Ouhlous, Ron T van Domburg, Folkert J Meijboom, Ad J J C Bogers, Jolien W Roos-Hesselink.   

Abstract

OBJECTIVE: To describe the very long-term outcome after surgical closure of an atrial septal defect (ASD).
DESIGN: Longitudinal cohort study of 135 consecutive patients who underwent surgical ASD repair at age <15 years between 1968 and 1980. The study protocol included ECG, echocardiography, exercise testing, N-terminal prohormone of brain natriuretic hormone, Holter monitoring and cardiac MRI. MAIN OUTCOME MEASURES: Survival, major events (cardiac reinterventions, stroke, symptomatic arrhythmia or heart failure) and ventricular function.
RESULTS: After 35 years (range 30-41), survival status was obtained in 131 of 135 patients (97%): five died (4%), including two sudden deaths in the last decade. Fourteen patients (16%) had symptomatic supraventricular tachyarrhythmias and six (6%) had a pacemaker implanted which was predicted by early postoperative arrhythmias. Two reoperations were performed. One ischaemic stroke occurred. Left ventricular (LV) and right ventricular (RV) ejection fractions (EF) were 58 ± 7% and 51 ± 6%, respectively. RVEF was diminished in 17 patients (31%) and in 11 (20%) the RV was dilated. Exercise capacity and quality of life were comparable to the normal population. No clear differences were found between ASD-II or sinus venosus type ASD.
CONCLUSIONS: Very long-term outcome after surgical ASD closure in childhood shows good survival and low morbidity. Early surgical closure prevents pulmonary hypertension and reduces the occurrence of supraventricular arrhythmias. Early postoperative arrhythmias are predictive for the need for pacemaker implantation during early follow-up, but the rate of late pacemaker implantation remains low. Although RVEF was unexpectedly found to be decreased in one-third of patients, the functional status remains excellent.

Entities:  

Keywords:  Cardiac Function; Congenital Heart Disease

Mesh:

Substances:

Year:  2013        PMID: 23886606     DOI: 10.1136/heartjnl-2013-304225

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  13 in total

Review 1.  Arrhythmias in structural heart disease.

Authors:  H Sawyer Gillespie; Charles C H Lin; Jordan M Prutkin
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

2.  Silent cerebral emboli following percutaneous closure of atrial septal defect in pediatric patients: a diffusion-weighted MRI study.

Authors:  Gonca Koç; Abdullah Özyurt; Selim Doğanay; Ali Baykan; S Burcu Görkem; M Sait Doğan; Özge Pamukçu; Kazım Üzüm; Abdulhakim Coşkun; Nazmi Narin
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

Review 3.  Atrial Fibrillation in Patients with Congenital Heart Disease.

Authors:  Tabitha G Moe; Victor A Abrich; Edward K Rhee
Journal:  J Atr Fibrillation       Date:  2017-06-30

Review 4.  Therapy of supraventricular and ventricular arrhythmias in adults with congenital heart disease-narrative review.

Authors:  Kristina Wasmer; Lars Eckardt; Helmut Baumgartner; Julia Köbe
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

5.  Impaired exercise capacity following atrial septal defect closure: an invasive study of the right heart and pulmonary circulation.

Authors:  Mário Santos; David Systrom; Stephen E Epstein; Anitha John; George Ruiz; Michael J Landzberg; Alexander R Opotowsky
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

Review 6.  [Arrhythmia in adults with congenital heart defects : Incidence, substrates, and mechanisms].

Authors:  Kristina Wasmer; Julia Köbe; Gerhard Diller; Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-05-23

7.  Evaluation of atrial septal defects with 4D flow MRI-multilevel and inter-reader reproducibility for quantification of shunt severity.

Authors:  Raluca G Chelu; Michael Horowitz; Dominica Sucha; Isabella Kardys; Delphine Ingremeau; Shreyas Vasanawala; Koen Nieman; Jean-Francois Paul; Albert Hsiao
Journal:  MAGMA       Date:  2018-08-31       Impact factor: 2.310

8.  Midterm follow-up of transthoracic device closure of an atrial septal defect using the very large domestic occluder (44-48 mm), a single Chinese cardiac center experience.

Authors:  Qiang Chen; Hua Cao; Gui-Can Zhang; Liang-Wan Chen; Fan Xu; Jia-Xin Zhang
Journal:  J Cardiothorac Surg       Date:  2017-09-02       Impact factor: 1.637

9.  Long-term mortality in patients with atrial septal defect: a nationwide cohort-study.

Authors:  Camilla Nyboe; Zarmiga Karunanithi; Jens Erik Nielsen-Kudsk; Vibeke E Hjortdal
Journal:  Eur Heart J       Date:  2018-03-21       Impact factor: 29.983

10.  Atrial fibrillation in patients with an atrial septal defect in a single centre cohort during a long clinical follow-up: its association with closure and outcome of therapy.

Authors:  Reinder Evertz; Manon Reinders; Charlotte Houck; Tim Ten Cate; Anthonie L Duijnhouwer; Rypko Beukema; Sjoerd Westra; Kevin Vernooy; Natasja M S de Groot
Journal:  Open Heart       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.